Kabivitrum Ab

Swedish Orphan Biovitrum Ab (publ)

Pharmacia & Upjohn Aktiebolag

Pharmacia Ab

Pharmacia & Upjohn Ab

Kabi Pharmacia Ab

Swedish Orphan Biovitrum Ab

Thomas Lundqvist

Ronny Lundin

Elvy Hokby

Sirkka Thome

Ebba Florin-robertsson

Gertrud Westin-sjodahl

Ebba Florin-Robertsson

Anders Strom

Jonas Fransson

Bo Ahlstrand

Birger T Hjertman

Birger Hjertman

Linda Fryklund

Barry Douglas Moore

Gertrud Elisabeth Westin-Sjodahl

Karin Limrell

Sirkka Thom E

Ulf Nilsson

Elvy H Okby

Barry D Moore

Staffan Castensson

Diane Moore

Gertrud Westin-Sjodahl

The present invention relates to compositions comprising anakinra, buffer, and optionally at least one osmolyte and optionally further excipients. Further, the present invention relates to use of said compositions for treatment of for example ophthalmic disorders.

Compositions comprising anakinra

The present invention relates to pharmaceutical compositions comprising anakinra as an active compound in the absence of sodium citrate. The said pharmaceutical compositions are useful for the treatment of IL-1 mediated disorders and for decreasing nociceptive pain during such treatment.

Citrate free pharmaceutical compositions comprising anakinra

The invention relates to a one-dose syringe comprising a first chamber with a freeze-dried composition comprising a protein in an amount of less than 1.4 mg, amino acid and stabilizer where the weight ratio between protein and amino acid versus stabilizer is less than 1.5 and in which the ratio of the weight of the dry component versus the cake volume in the first chamber is above 12 mg/ml, and a second chamber with an aqueous reconstitution solution with an injectable volume of less than 0.5 ml.

Syringe

Solution containing IGF-1

Process for manufacturing crystals of growth hormone and crystals

Protein formulation comprising growth hormone

Combined medical syringe and vial for administering subcutaneous

Medical syringe for administering subcutaneous injections

A dual-chamber cylinder ampoule is used for the mixture of a sensitive, solid medicament, with liquid which is caused to flow calmly through the medicament in order to avoid any shaking and mechanical influence. The mixing is preferably carried out at a pressure above atmospheric. An injection device for the preparation of an injection solution and a following injection of such solution includes first and second tubular members for enclosing and holding a dual-chamber cylinder ampoule, in which the dry medicament is kept separated from the liquid. When the two tubular members are being screwed together the liquid is calmly and gently mixed with the dry medicament and dissolves it, and the resulted solution can thereafter be injected by means of the dosage and administration mechanism, provided in one tubular member, through a needle arranged at the front end of the other tubular member.

Method and device for injection

Growing community of inventors

Stockholm, Sweden

Ebba Florin-Robertsson